Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice

Antonia Follenzi, Daniel Benten, Phyllis Novikoff, Louisa Faulkner, Sanj Raut, Sanjeev Gupta

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Transplantation of healthy cells to repair organ damage or replace deficient functions constitutes a major goal of cell therapy. However, the mechanisms by which transplanted cells engraft, proliferate, and function remain unknown. To investigate whether host liver sinusoidal endothelium could be replaced with transplanted liver sinusoidal endothelial cells, we developed an animal model of tissue replacement that utilized a genetic system to identify transplanted cells and induced host-cell perturbations to confer a proliferative advantage to transplanted cells. Under these experimental conditions, transplanted cells engrafted efficiently and proliferated to replace substantial portions of the liver endothelium. Tissue studies demonstrated that transplanted cells became integral to the liver structure and reacquired characteristic endothelial morphology. Characterization of transplanted endothelial cells by membrane markers and studies of cellular function, including synthesis and release of coagulation factor VIII, demonstrated that transplanted cells were functionally intact. Further analysis showed that repopulation of the livers of mice that model hemophilia A with healthy endothelial cells restored plasma factor VIII activity and corrected their bleeding phenotype. Our studies therefore suggest that transplantation of healthy endothelial cells should be considered for cell therapy of relevant disorders and that endothelial reconstitution with transplanted cells may offer an excellent paradigm for defining organspecific pathophysiological mechanisms.

Original languageEnglish (US)
Pages (from-to)935-945
Number of pages11
JournalJournal of Clinical Investigation
Volume118
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Hemophilia A
Endothelium
Endothelial Cells
Phenotype
Liver
Factor VIII
Cell- and Tissue-Based Therapy
Cell Transplantation
Animal Models
Transplantation
Cell Membrane
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. / Follenzi, Antonia; Benten, Daniel; Novikoff, Phyllis; Faulkner, Louisa; Raut, Sanj; Gupta, Sanjeev.

In: Journal of Clinical Investigation, Vol. 118, No. 3, 03.2008, p. 935-945.

Research output: Contribution to journalArticle

Follenzi, Antonia ; Benten, Daniel ; Novikoff, Phyllis ; Faulkner, Louisa ; Raut, Sanj ; Gupta, Sanjeev. / Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. In: Journal of Clinical Investigation. 2008 ; Vol. 118, No. 3. pp. 935-945.
@article{47b1ca083ad54c2ab70c13edc021910c,
title = "Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice",
abstract = "Transplantation of healthy cells to repair organ damage or replace deficient functions constitutes a major goal of cell therapy. However, the mechanisms by which transplanted cells engraft, proliferate, and function remain unknown. To investigate whether host liver sinusoidal endothelium could be replaced with transplanted liver sinusoidal endothelial cells, we developed an animal model of tissue replacement that utilized a genetic system to identify transplanted cells and induced host-cell perturbations to confer a proliferative advantage to transplanted cells. Under these experimental conditions, transplanted cells engrafted efficiently and proliferated to replace substantial portions of the liver endothelium. Tissue studies demonstrated that transplanted cells became integral to the liver structure and reacquired characteristic endothelial morphology. Characterization of transplanted endothelial cells by membrane markers and studies of cellular function, including synthesis and release of coagulation factor VIII, demonstrated that transplanted cells were functionally intact. Further analysis showed that repopulation of the livers of mice that model hemophilia A with healthy endothelial cells restored plasma factor VIII activity and corrected their bleeding phenotype. Our studies therefore suggest that transplantation of healthy endothelial cells should be considered for cell therapy of relevant disorders and that endothelial reconstitution with transplanted cells may offer an excellent paradigm for defining organspecific pathophysiological mechanisms.",
author = "Antonia Follenzi and Daniel Benten and Phyllis Novikoff and Louisa Faulkner and Sanj Raut and Sanjeev Gupta",
year = "2008",
month = "3",
doi = "10.1172/JCI32748",
language = "English (US)",
volume = "118",
pages = "935--945",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice

AU - Follenzi, Antonia

AU - Benten, Daniel

AU - Novikoff, Phyllis

AU - Faulkner, Louisa

AU - Raut, Sanj

AU - Gupta, Sanjeev

PY - 2008/3

Y1 - 2008/3

N2 - Transplantation of healthy cells to repair organ damage or replace deficient functions constitutes a major goal of cell therapy. However, the mechanisms by which transplanted cells engraft, proliferate, and function remain unknown. To investigate whether host liver sinusoidal endothelium could be replaced with transplanted liver sinusoidal endothelial cells, we developed an animal model of tissue replacement that utilized a genetic system to identify transplanted cells and induced host-cell perturbations to confer a proliferative advantage to transplanted cells. Under these experimental conditions, transplanted cells engrafted efficiently and proliferated to replace substantial portions of the liver endothelium. Tissue studies demonstrated that transplanted cells became integral to the liver structure and reacquired characteristic endothelial morphology. Characterization of transplanted endothelial cells by membrane markers and studies of cellular function, including synthesis and release of coagulation factor VIII, demonstrated that transplanted cells were functionally intact. Further analysis showed that repopulation of the livers of mice that model hemophilia A with healthy endothelial cells restored plasma factor VIII activity and corrected their bleeding phenotype. Our studies therefore suggest that transplantation of healthy endothelial cells should be considered for cell therapy of relevant disorders and that endothelial reconstitution with transplanted cells may offer an excellent paradigm for defining organspecific pathophysiological mechanisms.

AB - Transplantation of healthy cells to repair organ damage or replace deficient functions constitutes a major goal of cell therapy. However, the mechanisms by which transplanted cells engraft, proliferate, and function remain unknown. To investigate whether host liver sinusoidal endothelium could be replaced with transplanted liver sinusoidal endothelial cells, we developed an animal model of tissue replacement that utilized a genetic system to identify transplanted cells and induced host-cell perturbations to confer a proliferative advantage to transplanted cells. Under these experimental conditions, transplanted cells engrafted efficiently and proliferated to replace substantial portions of the liver endothelium. Tissue studies demonstrated that transplanted cells became integral to the liver structure and reacquired characteristic endothelial morphology. Characterization of transplanted endothelial cells by membrane markers and studies of cellular function, including synthesis and release of coagulation factor VIII, demonstrated that transplanted cells were functionally intact. Further analysis showed that repopulation of the livers of mice that model hemophilia A with healthy endothelial cells restored plasma factor VIII activity and corrected their bleeding phenotype. Our studies therefore suggest that transplantation of healthy endothelial cells should be considered for cell therapy of relevant disorders and that endothelial reconstitution with transplanted cells may offer an excellent paradigm for defining organspecific pathophysiological mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=40549129676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549129676&partnerID=8YFLogxK

U2 - 10.1172/JCI32748

DO - 10.1172/JCI32748

M3 - Article

C2 - 18274668

AN - SCOPUS:40549129676

VL - 118

SP - 935

EP - 945

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -